Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients > 3 to 17 Years of Age Requiring Long-term Parenteral Nutrition

Condition:   Manganese Safety in Pediatric Patients Interventions:   Drug: Tralement;   Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid Sponsor:   American Regent, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials